[ad_1] FDA approves use of Eisai (OTCPK: ESALY + 1.8%) FYCOMPA (perampanel) CIII, alone or in combination with other medicinal products, for the treatment of pediatric patients with partial seizures and at …
Read More »FDA approves expanded use of EySai – Eisai Co., Ltd.'s medical seizure. ADR (OTCMKTS: ESALY)
